Stock AOXG AOXING PHARMACEUTICAL COMPANY, INC.
Add to a list
To use this feature you must be a member
Log inSign up

All News Aoxing Pharmaceutical Company, Inc.

Equities

AOXG

US03740A1060

Market Closed - OTC Markets
Other stock markets
 09:30:00 2024-06-04 am EDT 		5-day change 1st Jan Change
0.0042 USD +5.00% Intraday chart for Aoxing Pharmaceutical Company, Inc. +5.00% +35.48%
2017 Aoxing Pharmaceutical Company, Inc. Executive Changes CI
2017 Aoxing Pharmaceutical Company, Inc. Announces Unaudited Consolidated Earnings Results for the Third Quarter and Nine Months Ended March 31, 2017 CI

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Aoxing Pharmaceutical Company, Inc. Executive Changes
CI
Aoxing Pharmaceutical Company, Inc. Announces Unaudited Consolidated Earnings Results for the Third Quarter and Nine Months Ended March 31, 2017
CI
Aoxing Pharmaceutical Company, Inc. Reports Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended December 31, 2016
CI
Aoxing Pharmaceutical Company, Inc. Announces Unaudited Consolidated Earnings Results for First Quarter Ended Sept. 30, 2016
CI
Aoxing Pharmaceutical Company, Inc. Reports Earnings Results for the Year Ended June 30, 2016
CI
Aoxing Pharmaceutical Company, Inc. Reports Earnings Results for the Third Quarter Ended March 31, 2016
CI
Aoxing Pharmaceutical Company, Inc. Reports Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended December 31, 2015; Provides Earnings Guidance for the Fiscal Year 2016
CI
Aoxing Pharmaceutical Company, Inc. Announces Executive Changes
CI
Aoxing Pharmaceutical Company, Inc. to Supply Zhongtongan to the Insurance System for the City of Shanghai
CI
Aoxing Pharmaceutical Company, Inc. Announces Opening of its New Narcotic and Psychotropic Drug Research Center
CI
Aoxing Pharmaceutical Company, Inc. Announces Management Changes
CI
Aoxing Pharmaceutical Company, Inc. Announces Unaudited Consolidated Earnings Results for the First Quarter Ended September 30, 2015
CI
Aoxing Pharmaceutical Company, Inc. Auditor Raises 'Going Concern' Doubt
CI
Aoxing Pharmaceutical Company, Inc. Announces Consolidated Earnings Results for the Year Ended June 30, 2015; Provides Earnings Guidance for the Fiscal Year 2016
CI
Aoxing Pharmaceutical Company, Inc. Announces Management Changes
CI
Aoxing Pharmaceutical Company, Inc. Announces Earnings Results for the Year Ended June 30, 2014
CI
Aoxing Pharmaceutical Company, Inc. Appoints Zhimin Li to its Board
CI
Aoxing Pharmaceutical Company, Inc. Announces Earnings Results for the Third Quarter and Nine Months Ended March 31, 2014
CI
Aoxing Pharmaceutical Company, Inc. Announces Earnings Results for the Second Quarter and Six Month Periods Ended December 31, 2013
CI
Aoxing Pharmaceutical Company, Inc. Announces Financial Results for the First Quarter Ended September 30, 2013
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. AOXG Stock
  4. News Aoxing Pharmaceutical Company, Inc.